> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Steps to Improve Combination Product Review
- URL: https://www.fdaweb.com/fda-steps-to-improve-combination-product-review/
- Published: 2016-12-02T12:00:00.000Z
- Updated: 2026-09-14T21:52:11.000Z
- Author: David McFarland
- Tags: Drugs, Devices, #legacy-id-D5137478

FDA has stepped up its focus on combination products and plans to finalize its guidance on human factors and GMPs this coming year. In an [update](http://email.prnewswire.com/wf/click?upn=E8kClcj4KJsTPR9EAHLkiAUqMbqE6qX4fwKS6vgkeo6bCXNufibsReHclzCQ5IHIsj2pPInVfiN6xPCVfApFtRyUy-2B-2FWF3LSUxXScTcro0CIvbtNQ3fAEBkbRQbaeW5twYehjQYhQ13v4jtbTtfu-2FYMCXULyLQH-2FifCc7dhrIVw-3D%5FnE9rxSXA5G4kxsTVkgv43tTJnmhvULg8&ref=fdaweb.com) on its combination products program, the agency also says it will issue a final rule on postmarket safety reporting, and it will update a guidance on classification of medical products. In order to improve internal standard operating procedures and policies for premarket reviews and compliance activities, FDA says it will draft and implement Staff Manual Guides to improve review areas, such as human factors labeling.